Sergio Rutella

Research Branch
Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Cathepsin-G expands the reach of CAR-T therapy in AML.

Cathepsin-G expands the reach of CAR-T therapy in AML.

Journal: Blood

Published: August 20, 2026

Generation of biologically responsive colon-like intestinal tissue patches from human induced pluripotent stem cells using a rapid co-differentiation platform.

Generation of biologically responsive colon-like intestinal tissue patches from human induced pluripotent stem cells using a rapid co-differentiation platform.

Journal: Stem cell research & therapy

Published: October 23, 2025

The immunotherapy landscape in AML: Defining knowledge gaps toward rational combinatorial strategies.

The immunotherapy landscape in AML: Defining knowledge gaps toward rational combinatorial strategies.

Journal: Seminars in hematology

Published: July 29, 2025

Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapy.

Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapy.

Journal: Journal for immunotherapy of cancer

Published: April 02, 2025

SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated Cytotoxicity.

SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated Cytotoxicity.

Journal: Blood cancer discovery

Published: June 06, 2024

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.

Journal: The lancet. Gastroenterology & hepatology

Published: November 18, 2023

CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia.

CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia.

Journal: Blood

Published: June 30, 2023

Escape from T-cell-targeting immunotherapies in acute myeloid leukemia.

Escape from T-cell-targeting immunotherapies in acute myeloid leukemia.

Journal: Blood

Published: May 01, 2023

Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.

Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.

Journal: British journal of haematology

Published: January 14, 2023

Gene Expression Profiling of FFPE Samples: A Titration Test.

Gene Expression Profiling of FFPE Samples: A Titration Test.

Journal: Technology in cancer research & treatment

Published: November 23, 2022

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.

Journal: The Journal of clinical investigation

Published: February 22, 2022

Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.

Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 06, 2021

Showing 1-12 of 87

Last Updated: 09/26/2026